SCHEMBL20060883

SCHEMBL20060883

O=C(c1ccc(OCCCCC2CCN(C(=O)[C@H](c3ccccc3)C(F)(F)F)CC2)cc1Cl)N1CC[C@@H](O)C1

nearest known ligand 0.38

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ GPR119 Q8TDV5 6/20 0.38
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ HTR2B P41595 1/20 0.36
▸ MAPK14 Q16539 1/20 0.36
▸ NAMPT P43490 1/20 0.35
▸ MRGPRX4 Q96LA9 1/20 0.35
▸ CXCR1 P25024 1/20 0.35
▸ CXCR2 P25025 1/20 0.35
▸ TEAD1 P28347 1/20 0.35
▸ TEAD3 Q99594 1/20 0.35
▸ THRB P10828 1/20 0.35
▸ MAOB P27338 2/20 0.34
▸ RORC P51449 1/20 0.34
▸ KCNA5 P22460 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22310514 0.91 GPR119 (0.41) GPR119CYP2C9CYP2C19HTR2BMAPK14
SCHEMBL20060881 0.87 GPR119 (0.38) GPR119MAOB
SCHEMBL20061055 0.85 GPR119 (0.47) GPR119THRBMAOB
SCHEMBL20060927 0.85 GPR119 (0.47) GPR119THRBMAOB
SCHEMBL20060844 0.85 GPR119 (0.46) GPR119
SCHEMBL20060919 0.85 HCRTR1 (0.42) GPR119
SCHEMBL22311335 0.84 NR1H2 (0.46) GPR119CYP2C9CYP2C19HTR2BMAPK14
SCHEMBL22311336 0.84 NR1H2 (0.46) GPR119CYP2C9CYP2C19HTR2BMAPK14
SCHEMBL30451610 0.84 NR1H2 (0.46) GPR119CYP2C9CYP2C19HTR2BMAPK14
SCHEMBL20060882 0.82 GPR119 (0.39) GPR119NAMPTTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018071317-A1 ARYL AND HETEROARYL ETHER DERIVATIVES AS LIVER X RECEPTOR BETA AGONISTS MERCK SHARP & DOHME CORP. (US) 2018-04-19 — — WO disclosed
WO-2018068295-A1 ARYL AND HETEROARYL ETHER DERIVATIVES AS LIVER X RECEPTOR β AGONISTS, COMPOSITIONS, AND THEIR USE MERCK SHARP & DOHME CORP. (US) 2018-04-19 — — WO disclosed
Send feedback